Drug
Allisartan isoproxil clinical trials
Keep track of what changes. Save the allisartan isoproxil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Shanghai Jiao Tong University School of Medicine (1) · Yan Li (1) · XueQing Yu (1) · Guangdong Provincial People's Hospital (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses allisartan isoproxil is read from its arms, and is right about nine times in ten.
Testing it · 4
- Intervention for High-normal Blood Pressure in Adults With Type 2 DiabetesRecruitingPhase 4XueQing YuNCT03264352Written as Allisartan Isoproxil
- Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial FibrillationActive, not recruitingPhase 4Shanghai Jiao Tong University School of MedicineNCT04111419Written as Allisartan Isoproxil
- Antihypertensive Treatment in Masked HypertensionCompletedPhase 4Yan LiNCT02893358Written as Allisartan Isoproxil
- Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal SubstudyWithdrawnPhase 4Guangdong Provincial People's HospitalNCT04978649Written as Allisartan Isoproxil
As the comparator · 2 — what is tested is compared with allisartan isoproxil
- Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney DamageRecruitingPhase 4Shanghai Jiao Tong University School of MedicineNCT07876544Written as Allisartan Isoproxil
- To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan IsoproxilCompletedPhase 3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT06500689Written as Allisartan Isoproxil
Codes
What other systems call allisartan isoproxil · ClinicalTrials.gg INT006457
- MeSH (NLM) C587132allisartan isoproxilOne source ClinicalTrials.gov
- UNII (FDA) DI4662MK4NALLISARTAN ISOPROXILConfirmed FDA, Wikidata
- Wikidata Q131807499allisartan isoproxilConfirmed FDA, Wikidata
- NCI Thesaurus C221838Allisartan IsoproxilOne source FDA
- DrugBank DB18880One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C587132 | allisartan isoproxil | One source ClinicalTrials.gov |
| UNII (FDA) | DI4662MK4N | ALLISARTAN ISOPROXIL | Confirmed FDA, Wikidata |
| Wikidata | Q131807499 | allisartan isoproxil | Confirmed FDA, Wikidata |
| NCI Thesaurus | C221838 | Allisartan Isoproxil | One source FDA |
| DrugBank | DB18880 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.